Aug 06, 2024 / 08:30PM GMT
Operator
Thank you for standing by. My name is Pam, and I will be your conference operator today. At this time, I would like to welcome everyone to the Ligand second quarter 2024 earnings webcast. (Operator Instructions)
I would now like to turn the conference over to Tavo Espinoza, the Chief Financial Officer of Ligand Pharmaceuticals Inc. You may begin.
Octavio Espinoza - Ligand Pharmaceuticals Inc - Chief Financial Officer
Good afternoon, everyone, and welcome to Ligand's second quarter earnings call. During the call today, we will review the financial results, we released after today's market close and offer commentary on our partner -- pipeline and business development activities, followed by a question and answer session.
Our earnings release and a link to today's webcast can be found in the Investor Relations section of our website at ligand.com. With me on the call today are CEO, Todd Davis; Senior Vice President of Investments and business development, Paul Hadden; and Senior Vice President of Investment and Head of Clinical Strategy. Dr.
Q2 2024 Ligand Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot